An ISO9001 Certified Supplier of Pharmaceutical Ingredients and Specialty Chemicals

NAMZARIC®

Drug Information Related Patent
Hold Company
ABBVIE
Learn More
Dosage and Administration
CAPSULE, EXTENDED RELEASE;ORAL
Specification
10MG;14MG
10MG;28MG
10MG;7MG
10MG;21MG
Indication
NAMZARIC® is indicated for the treatment of patients with moderate to severe Alzheimer type dementia.
Use
Instructions for Use
API
DONEPEZIL HYDROCHLORIDE
MEMANTINE HYDROCHLORIDE
API Structure
We Supply
DONEPEZIL HYDROCHLORIDE
Note:

USP/CP/EP/JP
Facility GMP
Product GMP
DMF preparing

MEMANTINE HYDROCHLORIDE
Note:

Commerical/USP
Facility GMP
China DMF/USMF/DMF/ASMF/PMDA/CDE/NMPA

null
Note:

null

Drug Patent
Patent NoExpiration Date
80390092029/3/24
8039009*PED2029/9/24
80582912029/12/5
81682092025/11/22
8168209*PED2026/5/22
81737082025/11/22
8173708*PED2026/5/22
82833792025/11/22
8283379*PED2026/5/22
82937942025/11/22
83297522025/11/22
8329752*PED2026/5/22
83384852025/11/22
83384862025/11/22
83620852025/11/22
8362085*PED2026/5/22
85808582025/11/22
85982332025/11/22
8598233*PED2026/5/22
API Patent
Patent NoExpiration Date
80582912029/12/5
81682092025/11/22
8168209*PED2026/5/22
81737082025/11/22
8173708*PED2026/5/22
82833792025/11/22
8283379*PED2026/5/22
82937942025/11/22
83384852025/11/22
83384862025/11/22
85808582025/11/22

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION
CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top